Danaher | DHR - Fremdkapital

Aktienkurs
178.80
Täglich Wechseln
-0.18 -0.10%
Monatlich
-2.77%
Jährlich
-10.30%
Q2 Prognose
173.46




Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bio Techne USD 260M 40M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Boston Scientific USD 11.01B 19M 2025-12
Bruker USD 1.85B 131.7M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.02B 2M 2025-12
Edwards Lifesciences USD 600M 1.7M 2026-03
ESCO Technologies USD 125M 56M 2025-12
Fortive USD 2.31B 189.4M 2025-12
Henry Schein USD 2.31B 157M 2025-12
Illumina USD 1.49B 496M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Keysight Technologies USD 2.53B 0 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
Medtronic USD 27.88B 255M 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Myriad Genetics USD 119.9M 400K 2025-12
OraSure Technologies USD 100K 17K 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Quidel USD 2.47B 2.47B 2025-12
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Roper Industries USD 9.75B 1.15B 2026-03
Stryker USD 14.86B 14M 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Waters USD 1.41B 460.24M 2025-12
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03